NADIDE
- UNII: 0U46U6E8UK
- Formula: C21H26N7O14P2.H
- Preferred Substance Name: NADIDE
- InChIKey: BAWFJGJZGIEFAR-NNYOXOHSSA-N
- 53-84-9
- 200-184-4
- .BETA.-NAD
- 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE 5'->5'-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN PYROPHOSPHATE) INNER SALT
- 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE, 5'-ESTER WITH ADENOSINE 5'-PYROPHOSPHATE, INNER SALT
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE) P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM INNER SALT
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 5'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM, HYDROXIDE, INNER SALT
- CO I
- CODEHYDROGENASE
- CODEHYDROGENASE I
- COENZYME I
- CO-I
- COZYMASE
- DIPHOSPHOPYRIDINE NUCLEOTIDE
- NAD
- NAD [MI]
- NAD(SUP +)
- NADIDE [INN]
- NADIDE [JAN]
- NADIDE [MART.]
- NADIDE [USAN]
- NADIDE [WHO-DD]
- NADIDUM
- NADIDUM [HPUS]
- NICOTINAMIDE ADENINE DINUCLEOTIDE
- NICOTINAMIDE ADENINE DINUCLEOTIDE [INCI]
- NICOTINAMIDE-ADENINE DINUCLEOTIDE
- NSC-20272
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
